Moat Ross bought KNSA
September 1, 2025 · Form 4 insider transaction
Moat Ross bought 2,477 shares of Kiniksa Pharmaceuticals International, plc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,477
Price
N/A
Total value
N/A
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2025
Filing dateSeptember 3, 2025
Shares owned after15,244
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.